Yasmin Genevieve Hernandez-Barco, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2023 | 198 | 0.780 |
Why?
|
Pancreatic Neoplasms | 8 | 2023 | 5256 | 0.780 |
Why?
|
Toll-Like Receptor 4 | 4 | 2010 | 565 | 0.710 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2023 | 506 | 0.670 |
Why?
|
Carcinoma, Pancreatic Ductal | 5 | 2023 | 1634 | 0.650 |
Why?
|
Cysts | 1 | 2023 | 678 | 0.640 |
Why?
|
Pancreatitis, Chronic | 1 | 2019 | 285 | 0.560 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 990 | 0.380 |
Why?
|
Gastroenterology | 3 | 2021 | 536 | 0.380 |
Why?
|
Dinoprostone | 3 | 2010 | 600 | 0.340 |
Why?
|
Colitis | 3 | 2010 | 1170 | 0.300 |
Why?
|
Epidermal Growth Factor | 1 | 2010 | 708 | 0.300 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2065 | 0.250 |
Why?
|
Dextran Sulfate | 3 | 2010 | 236 | 0.200 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 504 | 0.190 |
Why?
|
Endosonography | 1 | 2023 | 610 | 0.180 |
Why?
|
Cholangitis | 1 | 2020 | 108 | 0.170 |
Why?
|
Device Approval | 1 | 2021 | 163 | 0.170 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2541 | 0.160 |
Why?
|
Pancreaticoduodenectomy | 1 | 2020 | 503 | 0.140 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2010 | 1676 | 0.130 |
Why?
|
Pancreas | 2 | 2020 | 1686 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2020 | 594 | 0.120 |
Why?
|
Glycoproteins | 3 | 2010 | 2263 | 0.120 |
Why?
|
Triage | 1 | 2020 | 976 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 911 | 0.110 |
Why?
|
Cyclooxygenase 2 | 3 | 2010 | 611 | 0.110 |
Why?
|
Equipment Design | 1 | 2021 | 3582 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1170 | 0.100 |
Why?
|
Jejunal Diseases | 1 | 2011 | 50 | 0.100 |
Why?
|
Ileal Diseases | 1 | 2011 | 74 | 0.100 |
Why?
|
Azoxymethane | 1 | 2010 | 36 | 0.100 |
Why?
|
Prostaglandins | 1 | 2010 | 405 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2023 | 77449 | 0.080 |
Why?
|
Intestinal Mucosa | 2 | 2010 | 3036 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2214 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2291 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6773 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3605 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2010 | 14557 | 0.070 |
Why?
|
Mucous Membrane | 1 | 2010 | 673 | 0.070 |
Why?
|
Length of Stay | 1 | 2019 | 6309 | 0.070 |
Why?
|
Cell Proliferation | 3 | 2010 | 10481 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3086 | 0.070 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2011 | 868 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7913 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Humans | 17 | 2023 | 744343 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6364 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2216 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13284 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2010 | 3690 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4217 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2010 | 1978 | 0.050 |
Why?
|
Equipment Safety | 1 | 2021 | 264 | 0.050 |
Why?
|
Regeneration | 1 | 2009 | 1485 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
Hospitalization | 1 | 2019 | 10262 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5788 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10943 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2010 | 21827 | 0.040 |
Why?
|
Needles | 1 | 2020 | 449 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2009 | 1912 | 0.040 |
Why?
|
Signal Transduction | 2 | 2010 | 23403 | 0.040 |
Why?
|
Aged | 5 | 2020 | 163280 | 0.030 |
Why?
|
Mice | 4 | 2010 | 81183 | 0.030 |
Why?
|
Cell Line | 1 | 2010 | 15997 | 0.030 |
Why?
|
Male | 7 | 2020 | 350118 | 0.030 |
Why?
|
Middle Aged | 5 | 2020 | 213383 | 0.030 |
Why?
|
Female | 7 | 2020 | 380194 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14722 | 0.030 |
Why?
|
Colonoscopy | 1 | 2022 | 1367 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1584 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 56430 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9274 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1076 | 0.030 |
Why?
|
Adolescent | 1 | 2019 | 85781 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18029 | 0.020 |
Why?
|
Animals | 4 | 2010 | 168757 | 0.020 |
Why?
|
Inflammation | 1 | 2009 | 10638 | 0.020 |
Why?
|
Bacterial Translocation | 1 | 2009 | 73 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57776 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.020 |
Why?
|
Adult | 2 | 2019 | 214055 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1866 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2009 | 973 | 0.020 |
Why?
|
Chemokines | 1 | 2009 | 970 | 0.020 |
Why?
|
Risk Factors | 3 | 2020 | 72290 | 0.010 |
Why?
|
Life Style | 1 | 2014 | 3835 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4468 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5078 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2765 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10388 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2421 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15076 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2009 | 3474 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5217 | 0.010 |
Why?
|
Macrophages | 1 | 2009 | 5655 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7322 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8428 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23338 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17446 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10180 | 0.010 |
Why?
|